KRAS and lung adenocarcinoma: In this study, we analyzed exome sequencing data from 16 EGFR/KRAS/ALK-negative tumors and paired normal samples and an applicable expansion cohort of 54 EGFR/KRAS-negative lung adenocarcinomas to identify novel somatic mutations in lung adenocarcinomas of never-smokers.